Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

Alloy Therapeutics Inc.

Alloy Therapeutics is a biotechnology company dedicated to empowering scientists in the relentless pursuit of making better medicines for all. To this end, Alloy seeks to democratize access to foundational drug discovery platforms and services to scientists worldwide. Alloy's first platform, the ATX-Gx(TM) mouse platform, is a suite of transgenic mice designed for best-in-class in vivo discovery of fully human monoclonal antibodies. Alloy's partners include academic scientists, small and medium biotech, and Fortune 50 biopharma. Founded in 2018 and privately funded by visionary investors, Alloy Therapeutics is headquartered in Boston, Massachusetts with European labs in Cambridge, UK. As a reflection of our irrational commitment to the scientific community, 100% of our revenue from platforms and services is reinvested in innovation and supporting access to innovation. *


Period Start 2018-01-01 established
Products Industry ATX-Gx™ mouse platform
  Industry 2 transgenic mouse antibody technology
Person Person Anderson, Errik (Biomatics Capital 201811– Venture Partner + Alloy Therapeutics before Adimab + Compass Therapeutics)
  Street 44 Hartwell Avenue
  City 02421 Lexington, MA
    Address record changed: 2020-12-30
Basic data Employees n. a.
    * Document for �About Section�: Evotec SE. (12/21/20). "Press Release: Evotec Partners with Alloy Therapeutics to Expand Its Antibody Discovery Platform". Hamburg.
Record changed: 2021-01-13


Picture [iito] Made Without Love 650x80px

More documents for Alloy Therapeutics Inc.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Bionnale 2021 Digital Event 650x80px

» top